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ABSTRACT Double-stranded cDNA was synthesized from
hepatitis A virus (HAV) RNA- and inserted into the Pst I site of
pBR322. Restriction endonuclease digestion and cross-hybridiia-
tion of fragments yielded a map of overlapping cloned cDNAs that.
included at least 99% of the viral genome. Molecular clones con-
taining HAV cDNA were identified by. hybridizing cloned cDNA
to electrophoretically-resolved RNA from uninfected and.HAVY-in-
fected tissue culture cells. Cloned cDNA probes specificallyhy-
bridized to RNA from infected cells, and the predominant.species
identified had the characteristic genomic length of picornaviral
RNA (=7,500 nucleotides). A partial sequence from the.3'.end of
the genone revealed 414 bases in an open reading frame followed
by two closely spaced stop codons, a 60-base noncoding region,
and a tract of poly(A).
Hepatitis A virus (HAV) is an important cause of human hep-
atitis. In the United States it has been estimated.that >100,000
clinical cases occur annually (D. P. Francis, personal commu-
nication). HAV continues to be endemic in underdeveloped areas
of the world where infections usually occur in children, and
nearly all of the young adult population have antibody to HAV.
(1). Clinical hepatitis A and prevalence of antibody to. HAV are
decreasing in industrialized nations, resulting in increasing
numbers of adults susceptible to infection. Groups at risk in-
clude travelers to endemic areas, consumers of raw shellfish,.
male homosexuals, and contacts of very young children in day
care centers.
The host range of HAV is limited to man, apes (especially the
chimpanzee), and several species of New World 'monkeys (2).
Viral replication is limited to the liver, and excretion into the
stool appears to occur via the biliary system. The 27-nm virion.
of HAV was first observed in 1973 (3) and first isolated in tissue
culture in 1979 (4). Its cultivation remains difficult,, impeding
analysis of molecular structure and events in replication.
HAV has been classified as a picomavirus (5). It has a sedi-
mentation coefficient of approximately 160 S and a primary
buoyant density of 1.34 g/ml in CsCl. Virion capsid polypep-
tides of Mr 32,000, 26,000, 22,000, and 10,000 have been de-
scribed. The single-stranded infectious RNA genome is 6,700
to 8,100 nucleotides long and contains poly(A), presumably at
the 3' terminus. By analogy with other picornaviruses the RNA
should contain an open reading frame of about 6,500 nucleo-
tides, which.directs synthesis of a polyprotein that is post-trans-
lationally cleaved into virion proteins. These include the four
capsid proteins, a peptide linked to the 5' end of the genome
(VPg), a RNA-dependent RNA polymerase, anda protease (6-
9).
Previously, von der Helm et al. (10) described cloned cDNAs
of up to 1,000 base pairs that hybridized to RNA extracted from.
HAV labeled in tissue culture. We report here the cloning of
cDNA representing at least .99% -of the genome of HAV and
partial analysis of its sequence.
MATERIALS AND-METHODS
Source and Propagation of HAV. The HM-175 strain of HAV
was isolated from a family outbreak in Australia (11). HAV that
had been passaged twice in marmosets (Saguinus mystax and
Saguinus labiatus) (11) was inoculated into eight marmosets. A
20% (wt/vol) suspension of HAV-infected liver in phosphate-
buffered saline was injected intravenously, and animals were
monitored by serum enzymes and immunofluorescence of liver
biopsy (12). When maximum immunofluorescence was reached.
10-14 days after inoculation, the marmosets were killed and
their livers were immediately removed, minced, frozen in liq-
uid N2, and stored at -70'C until virus purification.
HAV was. also passaged 6 times in marmosets and 19 times
in secondary African green monkey. kidney (AGMK) monolay-
ers (11), which were used as a source of RNA for hybridization
(see below). Infected cultures were harvested at 21 days when
100% of the cells exhibited maximal immunofluorescence.
Virus Purification. Minced marmoset livers (total, 170 g) were
homogenized, extensively extracted with trichlorotrifluoroeth-
ane and chloroform, and treated with micrococcal nuclease (13).
Virus was monitored'by radioimmunoassay (14) and by electron
microscopy during successive sucrose, CsCl, and sucrose gra-
dients.
RNA Extraction and Characterization. Suspensions of pu-
rified HAV were incubated at 370C for 15 min with 500 ,Ag of
proteinase K per ml, after which NaDodSO4 was added to a
concentration of 0.5%, and incubation was continued for an ad-
ditional 30 min. After extraction with phenol. and then with
chloroform/isoamyl alcohol (24:1, vol/vol),. RNA was precipi-
tated in ethanol, redissolved, and, after removal of a portion for
analysis, reprecipitated. RNA was characterized by UV spec-
troscopy and agarose gel electrophoresis after denaturation with
1 M glyoxal/50% dimethyl sulfoxide (vol/vol) (15). Other por-
tions were used to analyze template quality and optimal. con-
ditions for cDNA synthesis as described in Results and Fig. 1.
RNA for-hybridization studies was prepared from uninfected
and HAV-infected (see above) ACGMK.cellsrby isolation of total
cytoplasmic RNA (16). Polyadenylylated RNA was isolated by
oligo(dT)-cellulose chromatography (17). RNA was transferred
to nitrocellulose paper after electrophoretic separation through
agarose gels containing glyoxal/dimethyl sulfoxide-denatured
RNA (18).
Abbreviations: HAV, hepatitis A virus; ds cDNA, -double-stranded cDNA;
kb, kilobase(s).
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Preparation of cDNA Clones. HAV RNA (0.8 jkg) derived
from marmoset liver served as a template for cDNA synthesis
using reverse transcriptase (120 units/ml) for 30 min. at 42.50C
in 160 .1A that contained 50 mM Tris-HCl (pH 8.3)/10 mM
MgCl2/100 mM KCI/500 p.M dATP/[a-32P]dCTP (0.025 Ci/
mmol; 1 Ci = 3.7 X 1010 Bq)/dGTP/TTP/I mM dithioery-
thritol/4 mM sodium pyrophosphate/(dT)12-18 at 30 pug/ml/
RNasin (2,000 units/ml). After addition of EDTA to 20 mM,
RNA cDNA hybrids were isolated by phenol extraction, col-
umn chromatography, and ethanol precipitation. The RNA
template was hydrolyzed in 0.3 M NaOH/0.7 M NaCI/5 mM
EDTA for 2 hr at 370C (8).
By using a modification of conditions optimized for polio-
virus cDNA template (8), the second strand of cDNA was syn-
thesized for 30 min at 37°C using the large (Klenow) fragment
of Escherichia coli DNA polymerase I(28 units/ml) in 10 mM
Tris HCl (pH 7.5)/5 mM MgCl2/5 mM dithioerythritol/50 ,uM
dATP/[a-32P]dCTP (0.45 Ci/mmol)/dGTP/TTP, and cDNA at
1 ,ug/ml.
After phenol extraction, column chromatography, and ethanol
precipitation, double-stranded cDNA (ds cDNA) was digested
for 1 hr at 370C using nuclease S1 at 10 units/ml (0.1 unit per
ng of ds cDNA) in 30 mM NaOAc (pH 4.5)/0.3 M NaCl/3 mM
ZnCl2/5% glycerol (vol/vol), followed by addition of EDTA to
35 mM, phenol and ether extraction, and dialysis against 10 mM
Tris HCl (pH 7.5) and 1 mM EDTA (8).
Homopolymer tails of dCMP were added to ds cDNA 4sing
terminal deoxynucleotidyltransferase (250. units/ml) for 20 min
at room temperature in 100 ,ul that contained 0.14 M potassium
cacodylate (pH 7.2)/1 mM CoCl2/0.2 mM dithioerythritol/nu-
clease-free bovine serum albumin (500 ,ug/ml)/200 ,uM dCTP
(8). After phenol extraction, 50% of the ds cDNA was ether-ex-
tracted and precipitated with ethanol.
The remaining tailed ds cDNA was applied to a 3-ml column
of Sepharose 4B in 20 mM Tris-HCl (pH 8.0)/0.6 M NaCl/2
mM EDTA (16). The first five 65-,l fractions containing ds cDNA
were pooled and precipitated in ethanol after the addition of
2 ,ug of yeast tRNA.
Plasmid vector pBR322, cleaved at the Pst I site and tailed
with dGMP, was hybridized to equimolar amounts of both tailed
ds cDNA preparations and used to transform E. coli HB1O1 by
standard procedures (16).
Analysis of cDNA Clones. Clones containing putative HAV
sequences were screened by cleaving recombinant plasmid
preparations with Pst I and sizing by gel electrophoresis. Cloned
cDNA inserts isolated from low melting point agarose (19) were
labeled by nick-translation and used as probes in hybridization
(i) to electrophoretically separated RNA bound to nitrocellulose
paper (described above) for establishing the identity of cloned
cDNA species, (ii) to DNA bound to nitrocellulose paper after
lysis of bacterial colonies in situ for further screening, and (iii)
to restriction, fragments of DNA resolved by electrophoresis
and bound to nitrocellulose paper for confirmation of tentative
restriction maps constructed on the basis of single and double
enzyme digests. Extent of RNA sequence not represented in
cDNA clones was determined by primer extension of HAV-in-
fected AGMK cytoplasmic RNA (8). Sequence determination of
cloned cDNA was by the method of Maxam and Gilbert (20).
Materials. The following sources were used: AGMK cells,
Flow Laboratories (Rockville, MD); micrococcal nuclease and
large fragment of E. coli DNA polymerase I, Boehringer Mann-
heim; proteinase K, Merck (Darmstadt, Federal Republic of
Germany); HPLC grade deoxynucleoside triphosphates, ICN;
[aI-32P]dCTP, New England Nuclear or Amersham; RNasin,. JEM
Research (Kensington, MD); reverse transcriptase, J. W. Beard,
Life Sciences (St. Petersberg, FL), through the National Can-
cer Institute; nuclease S1, P-L Biochemicals; terminal deoxynu-
cleotidyltransferase, nuclease-free bovine serum albumin, nick-
translation kits, and certain restriction endonucleases, Be-
thesda Research Laboratories; other restriction enzymes, New
England BioLabs; Sepharose 4B, Pharmacia; and oligo(dG)-tailed
pBR322, New England Nuclear. "2I-Labeled anti-HAV from
the HAVAB kit (Abbott) was used for detection of HAV by ra-
dioimmunoassay (14).
RESULTS
Virus Purification and RNA Characterization. Direct elec-
tron microscopic examination of purified HAV particles re-
vealed a homogeneous population of 27-nm virions. The yield
of virion RNA from eight marmoset livers was approximately
1.0 Aug and the A2w/A2w ratio was 2.0. Samples used for UV
spectroscopy were also denatured and analyzed by electropho-
resis through an agarose gel (15). HAV RNA contained a dis-
crete band comigrating with poliovirus type 1 RNA (approxi-
mately 7,440 nucleotides; refs. 7-9).
Analytic cDNA Synthesis. RNAs from several sources of HAV
and from poliovirus type 2 were compared for template quality
in cDNA synthesis under conditions optimal for poliovirus RNA
(Fig. 1). HAV RNA derived from liver or AGMK culture yielded
a series of transcripts ranging in size from slightly smaller than
the longest poliovirus type 2 cDNA to less than 500 nucleotides
(Fig. 1, lanes a, b, and b'; lanes e and e' show poliovirus type
2 cDNA). Presumably, degradation of HAV RNA prevented more
extensive synthesis of reverse transcript approaching the ex-
pected full length of 7,500 nucleotides. Other HAV cDNAs in
Fig. 1 (lanes c and d) revealed evidence of more extensive RNA
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FIG. 1. Alkaline agarose gel electrophoresis of cDNA from HAV
RNA and poliovirus type 2 RNA. By using conditions optimal for polio-
virus cDNA synthesis (8), RNAs (5 Ag/ml or less) were incubated for
60 min at 42.50C in 10 ,u1 containing 50mM Tris HCI (pH 8.3)/10 mM
MgCl2/50 mM KCI/500 ,uM dATP/[a-32P]dCTP (2 Ci/mmol)/dGTP/
TTP/0.4 mM dithioerythritol/4 mM sodium pyrophosphate/(dT)12_18
(30 ug/ml)/reverse transcriptase(80 units/ml). Two reactions (cDNAs
in lanes b' and e') also contained RNasin (2,000 units/ml). Reverse
transcripts from RNA templates: lane a, HAV RNA derived from mar-
moset liver; lanes b and b', HAV RNA from AGMK cells; lane c, HAV
RNA from human stool; lane d, HAV RNA from AGMK cells; lanes e
and e', poliovirus type 2 RNA. HAV RNAs were isolated as described
in Materials and Methods except that derived from human stool (lane
c), which was extracted from purified virus (a gift from S. Locarnini),
and an earlier preparation from AGMK cells (lane d) using modifica-
tions of standard procedures (5). Migration of A HindIu fragments (in
kb) is indicated on the left.
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degradation, but all gave a similar banding pattern that was dif-
ferent from that of poliovirus cDNAs.
The effect of varying several chemical constituents and phys-
ical parameters on yield and length of HAV cDNA was analyzed
bsy alkaline agarose gel electrophoresis and incorporation of
P]dCMP into trichloroacetic acid-precipitable product (data
not shown). Incubation for 30 min, or with reverse transcriptase
at 120 units/ml, or with 100 mM KC1 increased size and quan-
tity of cDNA when compared to that shown in Fig. 1 (lane b').
Denaturation of HAV RNA was not attempted because quantity
was limited and, in earlier experiments, heat or methylmercury
treatment of poliovirus RNA decreased yield and size of cDNA.
Preparation of cDNA Clones. A significant portion of HAV
cDNA transcribed under preparative conditions was 3,000-7,500
nucleotides long (Fig. 2, lane a). However, a wide size range
of ds cDNA molecules was produced (Fig. 2, lane b), and most
of the preparation was less than 2,000 nucleotides long after
nuclease SI digestion (lane c). Approximately 200 ng of ds cDNA
was synthesized. Ten nanograms of ds cDNA selected for large
size by gel filtration (Materials and Methods) yielded 232 tet-
racycline-resistant E. coli transformants. Cleavage with Pst I
demonstrated inserts of 1,000 base pairs or more in 43 of the
232 recombinant plasmids, designated pHAVLB. An additional
2,710 clones were obtained from 9 ng of unfractionated ds cDNA.
From this group, only pHAVL 1307 (described below) was ex-
tensively characterized.
Identity of Cloned cDNA. The identity of inserted DNAs in
recombinant plasmids was established by hybridization to RNA
bound to nitrocellulose paper after gel electrophoresis (Fig. 3).
A nick-translated probe prepared from the insert of pHAVLB
39 specifically hybridized to RNA from HAV-infected AGMK
cells (Fig. 3, lanes c' and e). Similar results (not shown) were
obtained when the inserts of pHAVLB 93 or pHAVLB 228 were
used as probes. The predominant band identified had the size
expected for genomic HAV RNA and comigrated with polio-
virus type 2 RNA. Diffuse hybridization to lanes containing RNA
from infected cells was probably due to RNA degradation. Nick-
translated pBR322 did not hybridize to any RNA species from
either HAV-infected or uninfected AGMK cells (data not shown),
thereby eliminating the possibility that a small amount of pBR322
contaminating the insert probes was responsible for specific hy-
bridization. None of the pHAVLB probes tested to date hy-
bridized to poliovirus RNA.
Restriction Map of Cloned HAV cDNAs. The restriction map
shown in Fig. 4 is based on data obtained from digests and on
hybridization of labeled inserts to fractionated DNA (data not
shown). Hybridization of an insert fragment from pHAVLB 228
[corresponding to the region from 2.4 to 3.0 kilobases (kb) in
Fig. 4] to DNA from bacterial colonies was used to select pHAVL
1307 (and pHAVLB 12 and pHAVLB 153, described in the leg-
end to Fig. 4) for further analysis. Plasmids pHAVLB 113, pHAVL
1307, pHAVLB 228, pHAVLB 148, and pHAVLB 207 overlap to
generate a map of about 7.4 kb, which represents at least 99%
of the genome of HAV. Inserts from other clones (as indicated
in Fig. 4) provided confirmation of overlap regions except for
that between pHAVLB 228 and pHAVLB 148. Nick-translated
pHAVLB 228 insert hybridized to the 1.5-kb Pst I fragment of
pHAVLB 148. The overlap as drawn is based on the assumption
that there is only one HincII site, present in both clones, in the
area about 4 kb from the 5' terminus of the genome. No other
restriction sites in this region were found by digestion with >30
other enzymes that have five- and six-base recognition sites. As
noted in the legend to Fig. 4, heterogeneity in one restriction
site (Nde I) was detected in the region about 2.5 kb from the
5' end of the viral RNA.
Primer Extension of Cloned cDNA. A labeled Pst I/BamHI
fragment (0.2-0.7 kb in Fig. 4) from pHAVLB 113 was used as
a primer for cDNA synthesis. When the template was cyto-
plasmic RNA from HAV-infected AGMK cells, the primer was
extended to give a discrete band (data not shown). Assuming
that the 5' termini from HAV RNAs of different passage levels
are conserved, we calculated that cloned cDNA extended to
within 50 bases of the 5' end of the genome. There was no primer
extension when RNA from uninfected AGMK cells was used as
a template.
Partial Sequence of the HAV Genome. The sequence of
cloned cDNA corresponding to the 3' end of HAV RNA is pre-
sented in Fig. 5. There is an open reading frame that extends
from the beginning of the sequence to a pair of nonsense co-
dons that are separated by six bases (bases 415-426). The sec-
ond nonsense codon is followed by 51 bases that do not contain
kb
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FIG. 2. Alkaline agarose gel electro-
phoresis ofproducts ofpreparative HAV ds
cDNA synthesis. Lane a, -3 ng of cDNA;
lane b, -2 ng of ds cDNA prior to nuclease
S1 digestion; lane c, -2 ng ofds cDNA after
nuclease S1 digestion. Migration of A
HindIII fragments (in kb) is indicated on
the left.
FIG. 3. Hybridization ofclonedcDNA insert probe toRNA. Nucleic
acids were denatured and electrophoresed (15); marker lanes (a-c) were
removed and stained with ethidium bromide (2 kg/ml) in 0.05MNaOH
for 40 min, followed by ethidium bromide (0.5 ,ug/ml) in 40 mM
Tris HOAc (pH 7.8)/1mM EDTA for 15 min and destaining in the same
buffer for 15 min. Lanes b'-e were transferred to nitrocellulose paper
(18) and hybridized for 36 hr at 420C with [32P]pHAVLB 39 insert (25
ng/ml; 5 x 108 dpm/pg) in 50% formamide (vol/vol)/0.75M NaCl/0.075
M trisodium citrate/50 mM sodium phosphate (pH 6.5)/0.2% Na-
DodS04/denatured sheared salmon sperm DNA (100 ug/ml)/0.04%
bovine serum albumin/polyvinyl pyrollidone/Ficoll. Lane a contained
400 ng of poliovirus type 2 RNA. Lanes b, b', and d contained cyto-
plasmicRNA from uninfected AGMK cells: lane b, 5 pMg; lane b', 20 pg;
and lane d, 1.5 pg, oligo(dT)-selected. Lanes c, c', and e contained cy-
toplasmic RNA from HAV-infected AGMK cells: lane c, 5 Ag; lane c',
20 ,ug; and lane e, 1.5 ,ug, oligo(dT)-selected. Autoradiographic expo-
sure for lanes b' and c' was one-eighth of that for lanes d and e. Mi-
gration of A Hindm fragments (in kb) is indicated on the left.
Biochemistry: Ticehurst et al.
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FIG. 4. Restriction map ofHAV cDNA clones. Viral RNA is estimated to be 7,450 nucleotides long excluding 3' poly(A), which is shown at the
right (thicker line). A composite map of cloned HAVcDNA and positions ofthe inserts from clones pHAVLB 113, pHAVL 1307, pHAVLB 228, pHAVLB
148, and pHAVLB 207 are shown immediately below the viral RNA. Recombinant plasmids pHAVLB 39, pHAVLB 108, and pHAVLB 93 have been
used for DNA sequence determination, to confirm regions of overlap, or to prepare insert probes. Other plasmids that support this map include
pHAVLB 153 (position 1.8-2.7 kb, relative to scale), pHAVLB 12 (2.3-3.3 kb), pHAVLB 87 (4.1-5.8 kb), pHAVLB 201 (5.2-6.7 kb), pHAVLB 38 (5.2-
6.9 kb), pHAVLB 56 (5.4-7.1 kb), PHAVLB 185 (5.5-7.5 kb), pHAVLB 24 (5.6-7.5 kb), and pHAVLB 122 (5.7-7.5 kb). Restriction sites have also been
mapped with Acc I (2.0 kb), Apa I (5.7 and 6.2 kb), Ava II (3.5 and 6.6 kb), BstEII (1.2 kb), HindIII (2.2 kb), Hpa I (0.4 kb), Nde I (1.2 kb), Pvu II
(0.8, 1.0, 3.0, 5.2, 5.5, and 7.1 kb), Sac 1 (3.0 kb), and Xba I (0.8 kb). There is also a site for Nde I (2.5 kb) in pHAVLB 12, pHAVLB 153, and pHAVL
1307, which is not present in pHAVLB 39. There are no sites for Bgl I, EcoRV, Hae II, Kpn I, Mlu I, Nae I, Nar I, Nru I, Pvu I, Sac II, Sal I, Sma
I, Sph I, Stu I, and TthlllI.
an open reading frame initiated by an ATG, followed by poly(A),
presumed to represent the 3' end of the viral genome. The
longest possible polypeptide encoded in the second and third
reading frames is 29 amino acids.
Preliminary sequence data (unpublished results) indicate that
an open reading frame begins with an ATG approximately 750
bases from the 5' end of HAV RNA and continues for at least
378 bases. Numerous stop codons in the other reading frames
preclude a significant translation product.
DISCUSSION
Molecular cloning of cDNA is a useful approach for the study
of RNA viruses such as HAV. Analysis of virion structure and
HAV replication has been limited by the persistence of cellular
functions in HAV-infected tissue culture, the long time re-
quired for virus proliferation, and the small quantities of HAV
obtainable. The availability of cloned HAV cDNA, made pos-
sible by using efficient conditions for ds cDNA synthesis that
were well characterized for another picornaviral RNA (8), should
be useful for deducing RNA and amino acid sequences and elu-
cidating the events of replication.
In an effort to produce cDNA clones that contained only HAV
sequences, HAV RNA was extracted from highly purified vi-
rions. HAV RNA probably represents a very small proportion
of nucleic acid from potential sources. The virus appears, from
electron microscopic (21) and biophysical data (unpublished data),
to be associated with intracellular membranous vesicles in vivo
and in vitro. It is possible that nonviral nucleic acid species could
contaminate HAV preparations by copurifying with the virus or
associated membranes. In earlier experiments the template for
cDNA was RNA extracted from HAV that had been incom-
pletely purified from marmoset liver. The cDNA clones de-
rived from this RNA were found to contain nonviral sequences
that were presumably of host origin (unpublished data). In the
experiments described here, liver homogenates were hydro-
carbon-extracted until an aqueous-organic interphase layer was
no longer detected. Micrococcal nuclease digestion was used to
eliminate unencapsidated nucleic acids. In addition, any viral
probe (labeled RNA or cDNA) used to screen clones might be
as contaminated with nonviral sequences as the template used
for cloning. Instead of using such a probe, pHAV inserts were
characterized by restriction analysis, cross-hybridization, and
hybridization to HAV RNA contained in RNA from a heterol-
ogous source.
It would be difficult at present to directly determine the se-
quence of HAV RNA as a reference, but analysis of cloned cDNA
sequences described here is consistent with a genome that has
the structural organization of other picornaviruses but does not
show significant homology to members of this group (7-9, 22).
Although there is only one known serotype of HAV, a restric-
tion site variation between HAV cDNA inserts was detected.
It is impossible to determine whether the alteration is due to
RNA sequence heterogeneity or an error in reverse transcrip-
tion. However, it would not be surprising to find sequence het-
erogeneity, because the HAV used in this study was not cloned.
The Nde I site variation (2.5 kb from the 5' end of the genome)
occurs in an area that corresponds to the sequence coding for
the NH2 terminus of VP1 in poliovirus RNA (7-9). This poly-
peptide is thought to be important in picornaviral surface struc-
ture and in immunity (23-25). In other picornaviruses, strain
and serotype differences are often manifested by changes in
VP1 RNA sequence (9, 26, 27).
It may be feasible to use HAV cDNA as a probe to detect
viral or virus-related sequences from a variety of specimens.
Experiments (data not shown) using a dot blot assay (18) in-
dicate that cloned HAV cDNA is a sensitive and specific probe
for detecting viral RNA molecules in cytoplasmic RNA from
tissue culture.
Because many of the same limitations for obtaining the RNA
Proc. Natl. Acad. Sci. USA 80 (1983)
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27 54
TCT CGA GAT GTT CAG ATT GAT AAT CTT GAT TTG ATT GGA CAA AAA ATT GTA GAT
Ser Arq Asp Val Gin Ile Asp Asn Lou Asp Lou Ile Gly Gin Lys Ilie Val Asp
Leu Giu MET Ph. Arq Lou Ile Ilo Lou Ile . Lou Asp iys Lys Leu MET
Ser Arq Cys Set Asp Set Ph. Asp Trp Thr Lys Asn Cys Arq
1 108
GAG TTT AAG AAA CTT GGC ATG ACA GCT ACT TCT GCT GAC AAG AAT GTA CCT CAG
Glu Ph. Lys Lys Lou Giy MET Thr Aia Thr Set Aia Asp Lys Asn Vai Pro Gin
Set Lou Arq Asn Lou Aia Gin Lou Lou Lou Leu Thr Arq MET Tyr Leu S-ar
Vai Giu Thr Trp His Asp Sor Tyr Ph. Cys Gin Giu Cys Thr Ser Aia
135 162
CTG AAA CCA GTT TCG GAA TTG ACT TTT CTC AAA AGA TCT TTC AAT TTG GTA GAG
Leu Lys Pro Vai Sor Giu Lou Thr Pho Lou Lys Arg Sot Ph. Asn Leu Vai Giu
Asn Gin Ph. Arg Asn Lou Ph. Sot Lys Asp Lou Ser Ile Trp Arq
Giu Thr Ser Ph. Giy Ile Asp Pho Sor Gin Lys Ilo Pho Gin Ph. Giy Arq Giy
189 216
GAT AGA ATT AGA CCT GCA ATT TCG GAA AAA ACA ATT TGG TCT TTA ATA GCA TGG
Asp Arq Ile Arg Pro Aia Ilo Sor Giu Lys Thr Ile Trp Ser Lou Ile Aia Trp
Ile Giu Lou Asp Lou Gin Pho Arq Lys Lys Gin Pho Giy Lou His Giy
Asn Thr Cys Asn Pho Giy Lys Asn Asn Lou Vai Pho Asn Sor MET Aia
243 270
CAG AGA AGT AAC OCT GAO TTT GAG CAG AAT TTA GAA AAT OCT CAG TOG TTT OCT
Gin Arq Sor Asn Ala Giu Pho Giu Gin Asn Lou Giu Asn Aia Gin Trp Pho Aia
Arq Giu Vai Thr Lou.Sor Lou Sor Arg Ii. Lys MET Lou Sor Giy Lou Lou
Giu Lys Arg Vai Aia Giu Pho Arg Lys Cys Sor Vai Vai Cys Ph.
297 324
TTT ATG CAT GGC TAT GAO TTT TAT CAG AAA TTT TAT TAT TTT OTT CAG TCC TGT
Ph. MET His Giy Tyr Giu Pho Tyr Gin Lys Pho Tyr Tyr Pho Vai Gin Sot Cys
Lou Cys MET Aia MET Sot Pho Ile Arq Asn Pho Ilo Ii. Lou Pho Sot Pro Vai
Tyr Aia Trp Lou Vai Lou Sot Giu Ii. Lou Lou Pho Cys Sot Vai Lou Ph.l
351 378
TTG GAG AAA GAO ATG ATA GAA TAC AGA CTT AAA TCT TAT OAT TOO TOO AGA ATG
Lou Giu Lys Giu MET Ilo Giu Tyt Arq Lou Lys Sot Tyt Asp Ttp Trp Arq MET
Trp Arq Lys Arq Asn Tht Asp Lou Asn Lou MET Ile Giy Giy Giu
Gly Giu Arq Asp Asp Atq Ile Gin Tht Ile Lou Lou Vai Glu Asn Giu
605 432
AGA TTT TAT GAC CAG TOT TTC ATT TOT GAC CTT TCA TGA TTT OTT TAA ACA AAT
Arq Ph. Tyr Asp Gin Cys Ph. Ile Cys Asp Lou Sot Pho Vai Tht Asn
Asp Ph. MET Tht Sot Vai Sot Pho Vai Tht Ph. His Asp Lou Ph. Lys Gin Ilo
I1e Lou Pro Vai Ph. His Lou Pro Ph. MET Ilo Cys Lou Asn Lys Ph.
659 686
TTT CTT AAA ATT TCT GAO OTT TOT TTA TTT CTT TTA TCA GTA AAT AAA AAA AAA
Ph. Leu Lys Ile Sot Glu Val Cys Lou Pho Lou Lou Sot Vai Asn Lys Lys Lys
Ph. Lou Lys Ph. Lou Arq Ph. Val Tyt Ph. Ph. Tyr Gin Ile Lys Lys Lys
Set Asn Pho Giy Lou Ph. Ilo Sot Ph. Ilo Sot Lys Lys Lys Lys
513
AAA AAA
Lys Lys
Lys
Lys
FIG. 5. Nucleotide sequence of cloned cDNA corresponding to the
HAV genome 3' terminus. Sequence was determined for the insert from
pHAVLB 93 (20), starting near the Ava I/Xho I site (Fig. 4). Possible
translation products are listed in all three reading frames below the
nucleotide sequence, with the frame probably used for viral protein up-
permost. Following poly(A) (bases 478-492), poly(G) links cloned HAV
cDNA to pBR322 (data not shown).
of HAV apply to its proteins, there is no information about amino
acid sequences and little is known about the immunologic de-
terminants that elicit the polyclonal antibody response to in-
fection. Antisera directed against specific HAV polypeptides
have not yet been identified. It may be possible to prepare such
antisera from synthetic peptides or from cDNAs expressed in
prokaryotes (28) or eukaryotes (29) as has been done for other
picornaviruses (24, 25). Immunogenic peptides or polypeptides
would have obvious potential for vaccine development.
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